September/October 2016

PCSK9 inhibitors are among the most significant tools targeting high cholesterol to arrive since the first statins were approved by the FDA.

Closed-system transfer devices reduce hazardous drug exposure and prevent the transfer of environmental contaminants into parenteral medications.

To this day, internet and mail-order pharmacy services are still not what analysts predicted they would be.

The University of Pittsburgh’s Masters of Science in Pharmacy Business Administration program catalyzes the critical skills and expertise necessary for students to reach their professional goals.

With the high number of oral therapies hitting the market, specialty pharmacies are now on the frontline of cancer treatment.

A proven partner to position your brand for success.

Health care practitioners need to prepare for myriad questions regarding biosimilars and follow-on biologic drugs as they enter the market.

Access to electronic medical records is a key factor that distinguishes health-system specialty pharmacies from their nonintegrated competitors.

How well are we using the longest lever available to affect hundreds of billions of dollars in wasted health care spending?

Specialty pharmacy switching is a growing concern for providers and patients.

Artificial intelligence has evolved to the point that it can significantly augment the work done by physicians, pharmacists, and health coaches.

Core services are basic to specialty pharmacy offerings, while enhanced services are only provided with payment from a third party, usually a drug manufacturer.

Specialty drugs can alter or eradicate diseases to increase both the quality of life and length of lifespan overall, but this progress and innovation comes with a price tag.

The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow, will allow pharmacists to obtain continuing education credits while staying on top of the latest oncology advances.